Back to Journals » Core Evidence » Volume 5

Core Evidence

Archive: Volume 5, 2010

Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

Douglas R Jeffery, Emily Poole Pharr

Core Evidence 2010, 5:107-112

Published Date: 8 December 2010

Pitavastatin: evidence for its place in treatment of hypercholesterolemia

Peter Alagona, Jr

Core Evidence 2010, 5:91-105

Published Date: 22 October 2010

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al

Core Evidence 2010, 5:61-76

Published Date: 24 September 2010

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Renee M Sullivan, Brian Olshansky

Core Evidence 2010, 5:49-59

Published Date: 15 September 2010

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Sonia Okuyama, Rene Gonzalez, Karl D Lewis

Core Evidence 2010, 5:39-48

Published Date: 1 September 2010

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Kristen Kulasa, Steven Edelman

Core Evidence 2010, 5:23-37

Published Date: 13 August 2010

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Eliana Krulig, Kenneth B Gordon

Core Evidence 2010, 5:11-22

Published Date: 5 July 2010

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Markos Poulopoulos, Cheryl Waters

Core Evidence 2010, 5:1-10

Published Date: 22 December 2009